National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 812329

History of Changes from the VAERS Wayback Machine

First Appeared on 8/14/2019

VAERS ID: 812329
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:2018-10-23
Onset:2018-12-27
Submitted:0000-00-00
Entered:2019-05-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU4: INFLUENZA (SEASONAL) (QIV DRESDEN) / GLAXOSMITHKLINE BIOLOGICALS AFLBA322CA / UNK - / OT

Administered by: Other      Purchased by: ??
Symptoms: Acute respiratory distress syndrome, Cough, Death, Influenza, Pyrexia, Respiratory disorder, Respiratory distress, Vaccination failure, Dependence on respirator, Influenza A virus test positive, Polymerase chain reaction positive

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2019-01-16
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: PCR; Result Unstructured Data: Test Result: Influenza A NA, Test Result Unit: unknown
CDC 'Split Type': DEGLAXOSMITHKLINEDE201907

Write-up: ARDS; respiratory disorder requiring ventilation; respiratory disorder requiring ventilation; Influenza A; Respiratory distress; fever; Dry cough; Vaccination failure; This case was reported by a physician via regulatory authority and described the occurrence of ards in a 72-year-old female patient who received Flu Seasonal QIV Dresden (Influsplit Tetra 2018/2019) (batch number AFLBA322CA, expiry date unknown) for prophylaxis. On 23rd October 2018, the patient received Influsplit Tetra 2018/2019 (intramuscular). On 27th December 2018, 65 days after receiving Influsplit Tetra 2018/2019, the patient experienced influenza a virus infection, vaccination failure (serious criteria GSK medically significant), respiratory distress (serious criteria GSK medically significant), fever and dry cough. On an unknown date, the patient experienced ards (serious criteria death and GSK medically significant), respiratory disorder nos (serious criteria death) and dependence on ventilator (serious criteria death and GSK medically significant). On 16th January 2019, the outcome of the ards, respiratory disorder nos and dependence on ventilator were fatal. On an unknown date, the outcome of the influenza a virus infection, vaccination failure, respiratory distress, fever and dry cough were unknown. The patient died on 16th January 2019. The reported cause of death was respiratory disorder, acute respiratory distress syndrome and dependence on ventilator. It was unknown if the reporter considered the ards, respiratory disorder nos, dependence on ventilator, influenza a virus infection, vaccination failure, respiratory distress, fever and dry cough to be related to Influsplit Tetra 2018/2019. Additional details: Age at vaccination was not reported however patient could be 71 or 72 years old at time of vaccination. On an unknown date, PCR was performed with results Influenza A NA. PEI assessment of causality was reported as Unclassifiable. Batch number for Influsplit Tetra 2018/2019 was reported as ASLBA322CA however on batch number review it was corrected to AFLBA322CA. Initial information was reported by a physician via regulatory authority on 30th April 2019. ARDS , espiratory disorder nos, Dependence on ventilator,influenza a virus infection, vaccination failure, respiratory distress, fever and dry cough. Lab Comments: On an unknown date PCR was performed with result Influenza A NA.; Reported Cause(s) of Death: Respiratory disorder; Acute respiratory distress syndrome; Dependence on ventilator


Changed on 12/24/2020

VAERS ID: 812329 Before After
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:2018-10-23
Onset:2018-12-27
Submitted:0000-00-00
Entered:2019-05-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU4: INFLUENZA (SEASONAL) (QIV DRESDEN) / GLAXOSMITHKLINE BIOLOGICALS AFLBA322CA / UNK - / OT

Administered by: Other      Purchased by: ??
Symptoms: Acute respiratory distress syndrome, Cough, Death, Influenza, Pyrexia, Respiratory disorder, Respiratory distress, Vaccination failure, Dependence on respirator, Influenza A virus test positive, Polymerase chain reaction positive

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2019-01-16
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: PCR; Result Unstructured Data: Test Result: Influenza A NA, Test Result Unit: unknown
CDC 'Split Type': DEGLAXOSMITHKLINEDE201907

Write-up: ARDS; respiratory disorder requiring ventilation; respiratory disorder requiring ventilation; Influenza A; Respiratory distress; fever; Dry cough; Vaccination failure; This case was reported by a physician via regulatory authority and described the occurrence of ards in a 72-year-old female patient who received Flu Seasonal QIV Dresden (Influsplit Tetra 2018/2019) (batch number AFLBA322CA, expiry date unknown) for prophylaxis. On 23rd October 2018, the patient received Influsplit Tetra 2018/2019 (intramuscular). On 27th December 2018, 65 days after receiving Influsplit Tetra 2018/2019, the patient experienced influenza a virus infection, vaccination failure (serious criteria GSK medically significant), respiratory distress (serious criteria GSK medically significant), fever and dry cough. On an unknown date, the patient experienced ards (serious criteria death and GSK medically significant), respiratory disorder nos (serious criteria death) and dependence on ventilator (serious criteria death and GSK medically significant). On 16th January 2019, the outcome of the ards, respiratory disorder nos and dependence on ventilator were fatal. On an unknown date, the outcome of the influenza a virus infection, vaccination failure, respiratory distress, fever and dry cough were unknown. The patient died on 16th January 2019. The reported cause of death was respiratory disorder, acute respiratory distress syndrome and dependence on ventilator. It was unknown if the reporter considered the ards, respiratory disorder nos, dependence on ventilator, influenza a virus infection, vaccination failure, respiratory distress, fever and dry cough to be related to Influsplit Tetra 2018/2019. Additional details: Age at vaccination was not reported however patient could be 71 or 72 years old at time of vaccination. On an unknown date, PCR was performed with results Influenza A NA. PEI assessment of causality was reported as Unclassifiable. Batch number for Influsplit Tetra 2018/2019 was reported as ASLBA322CA however on batch number review it was corrected to AFLBA322CA. Initial information was reported by a physician via regulatory authority on 30th April 2019. ARDS , espiratory disorder nos, Dependence on ventilator,influenza a virus infection, vaccination failure, respiratory distress, fever and dry cough. Lab Comments: On an unknown date PCR was performed with result Influenza A NA.; Reported Cause(s) of Death: Respiratory disorder; Acute respiratory distress syndrome; Dependence on ventilator


Changed on 12/30/2020

VAERS ID: 812329 Before After
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:2018-10-23
Onset:2018-12-27
Submitted:0000-00-00
Entered:2019-05-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU4: INFLUENZA (SEASONAL) (QIV DRESDEN) / GLAXOSMITHKLINE BIOLOGICALS AFLBA322CA / UNK - / OT

Administered by: Other      Purchased by: ??
Symptoms: Acute respiratory distress syndrome, Cough, Death, Influenza, Pyrexia, Respiratory disorder, Respiratory distress, Vaccination failure, Dependence on respirator, Influenza A virus test positive, Polymerase chain reaction positive

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2019-01-16
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: PCR; Result Unstructured Data: Test Result: Influenza A NA, Test Result Unit: unknown
CDC 'Split Type': DEGLAXOSMITHKLINEDE201907

Write-up: ARDS; respiratory disorder requiring ventilation; respiratory disorder requiring ventilation; Influenza A; Respiratory distress; fever; Dry cough; Vaccination failure; This case was reported by a physician via regulatory authority and described the occurrence of ards in a 72-year-old female patient who received Flu Seasonal QIV Dresden (Influsplit Tetra 2018/2019) (batch number AFLBA322CA, expiry date unknown) for prophylaxis. On 23rd October 2018, the patient received Influsplit Tetra 2018/2019 (intramuscular). On 27th December 2018, 65 days after receiving Influsplit Tetra 2018/2019, the patient experienced influenza a virus infection, vaccination failure (serious criteria GSK medically significant), respiratory distress (serious criteria GSK medically significant), fever and dry cough. On an unknown date, the patient experienced ards (serious criteria death and GSK medically significant), respiratory disorder nos (serious criteria death) and dependence on ventilator (serious criteria death and GSK medically significant). On 16th January 2019, the outcome of the ards, respiratory disorder nos and dependence on ventilator were fatal. On an unknown date, the outcome of the influenza a virus infection, vaccination failure, respiratory distress, fever and dry cough were unknown. The patient died on 16th January 2019. The reported cause of death was respiratory disorder, acute respiratory distress syndrome and dependence on ventilator. It was unknown if the reporter considered the ards, respiratory disorder nos, dependence on ventilator, influenza a virus infection, vaccination failure, respiratory distress, fever and dry cough to be related to Influsplit Tetra 2018/2019. Additional details: Age at vaccination was not reported however patient could be 71 or 72 years old at time of vaccination. On an unknown date, PCR was performed with results Influenza A NA. PEI assessment of causality was reported as Unclassifiable. Batch number for Influsplit Tetra 2018/2019 was reported as ASLBA322CA however on batch number review it was corrected to AFLBA322CA. Initial information was reported by a physician via regulatory authority on 30th April 2019. ARDS , espiratory disorder nos, Dependence on ventilator,influenza a virus infection, vaccination failure, respiratory distress, fever and dry cough. Lab Comments: On an unknown date PCR was performed with result Influenza A NA.; Reported Cause(s) of Death: Respiratory disorder; Acute respiratory distress syndrome; Dependence on ventilator


Changed on 5/7/2021

VAERS ID: 812329 Before After
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:2018-10-23
Onset:2018-12-27
Submitted:0000-00-00
Entered:2019-05-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU4: INFLUENZA (SEASONAL) (QIV DRESDEN) / GLAXOSMITHKLINE BIOLOGICALS AFLBA322CA / UNK - / OT

Administered by: Other      Purchased by: ??
Symptoms: Acute respiratory distress syndrome, Cough, Death, Influenza, Pyrexia, Respiratory disorder, Respiratory distress, Vaccination failure, Dependence on respirator, Influenza A virus test positive, Polymerase chain reaction positive

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2019-01-16
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: PCR; Result Unstructured Data: Test Result: Influenza A NA, Test Result Unit: unknown
CDC 'Split Type': DEGLAXOSMITHKLINEDE201907

Write-up: ARDS; respiratory disorder requiring ventilation; respiratory disorder requiring ventilation; Influenza A; Respiratory distress; fever; Dry cough; Vaccination failure; This case was reported by a physician via regulatory authority and described the occurrence of ards in a 72-year-old female patient who received Flu Seasonal QIV Dresden (Influsplit Tetra 2018/2019) (batch number AFLBA322CA, expiry date unknown) for prophylaxis. On 23rd October 2018, the patient received Influsplit Tetra 2018/2019 (intramuscular). On 27th December 2018, 65 days after receiving Influsplit Tetra 2018/2019, the patient experienced influenza a virus infection, vaccination failure (serious criteria GSK medically significant), respiratory distress (serious criteria GSK medically significant), fever and dry cough. On an unknown date, the patient experienced ards (serious criteria death and GSK medically significant), respiratory disorder nos (serious criteria death) and dependence on ventilator (serious criteria death and GSK medically significant). On 16th January 2019, the outcome of the ards, respiratory disorder nos and dependence on ventilator were fatal. On an unknown date, the outcome of the influenza a virus infection, vaccination failure, respiratory distress, fever and dry cough were unknown. The patient died on 16th January 2019. The reported cause of death was respiratory disorder, acute respiratory distress syndrome and dependence on ventilator. It was unknown if the reporter considered the ards, respiratory disorder nos, dependence on ventilator, influenza a virus infection, vaccination failure, respiratory distress, fever and dry cough to be related to Influsplit Tetra 2018/2019. Additional details: Age at vaccination was not reported however patient could be 71 or 72 years old at time of vaccination. On an unknown date, PCR was performed with results Influenza A NA. PEI assessment of causality was reported as Unclassifiable. Batch number for Influsplit Tetra 2018/2019 was reported as ASLBA322CA however on batch number review it was corrected to AFLBA322CA. Initial information was reported by a physician via regulatory authority on 30th April 2019. ARDS , espiratory disorder nos, Dependence on ventilator,influenza a virus infection, vaccination failure, respiratory distress, fever and dry cough. Lab Comments: On an unknown date PCR was performed with result Influenza A NA.; Reported Cause(s) of Death: Respiratory disorder; Acute respiratory distress syndrome; Dependence on ventilator

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=812329&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166